| 摘要 |
<p>Methods are disclosed for the treatment of cancers in humans utilizing endogenous suramin-induced sulfated glycosaminoglycans (GAGs). Pharmaceutical injectable compositions containing the sulfated GAGs are also disclosed, and a method of isolating endogenous suramin-induced sulfated GAGs from a patient being treated with suramin, is also provided.</p> |
